References
- Camilleri A, Vassallo N. The centrality of mitochondria in the pathogenesis and treatment of Parkinson’s disease. CNS Neurosci Ther. 2014;20:591–602.
- Pissadaki EK, Bolam JP. The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson’s disease. Front Comput Neurosci. 2013;7:13.
- Schapira AHV, Cooper JM, Dexter D, et al. Mitochondrial Complex I deficiency in Parkinson’s disease. J Neurochem. 1990;54:823–827.
- Veech RL, Todd King M, Pawlosky R, et al. The “Great” controlling nucleotide coenzymes. IUBMB Life. 2019;71:565–579.
- Newman JC, Verdin E. β-Hydroxybutyrate: a signalling metabolite. Annu Rev Nutr. 2017;37:51–76.
- Fu SP, Wang JF, Xue WJ, et al. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms. J Neuroinflammation. 2015;12:1–14.
- Tieu K, Ramasamy R, Przedborski S, et al. D-b-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Investig. 2003;112:892–901.
- Yang X, Cheng B. Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. J Mol Neurosci. 2010;42:145–153.
- van Itallie TB, Nonas C, Rocco A, et al. Treatment of Parkinson disease with diet-induced hyperketonemia : a feasibility study. Neurology. 2005;64:728–730.
- Krikorian R, Shidler MD, Summer SS, et al. Nutritional ketosis for mild cognitive impairment in Parkinson’s disease: a controlled pilot trial. Clin Parkinsonism Relat Disord. 2019;1:41–47.
- Phillips MCL, Murtagh DKJ, Gilbertson LJ, et al. Low-fat versus ketogenic diet in Parkinson’s disease: a pilot randomized controlled trial. Mov Disord. 2018;33:1306–1314.
- Desrochers S, David F, Garneau M, et al. Metabolism of R- and S-1,3-butanediol in perfused livers from meal-fed and starved rats. Biochem J. 1992;285:647–653.
- Soto-mota A, Norwitz NG, Clarke K. Why a D-β-hydroxybutyrate monoester? Biochem Soc Trans. 2020;48:51–59.
- D’Agostino DP, Pilla R, Held HE, et al. Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am J Physiol. 2013;304:829–836.
- Norwitz NG, Dearlove DJ, Lu M, et al. A ketone ester drink enhances endurance exercise performance in Parkinson’s disease. Front Neurosci. 2020;14:584130.